Underestimation of Atypical Lobular Hyperplasia and Lobular Carcinoma in Situ at Stereotaxic 11-Gauge Vacuum-Assisted Breast Biopsy
Open Access
- 1 September 2013
- journal article
- research article
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 11 (3) , 825-835
Abstract
The aims of this study are to determine the frequency of diagnosis of atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) at stereotaxic-guided 11-gauge vacuum-assisted breast biopsy (VABB) and to assess the rate of underestimation of these at subsequent surgical excision and follow-up. Moreover, we aimed to define clinical, radiological and histological features of nonpalpable lesions in core biopsies that predict the lesion upgrade. Retrospective review of 11-gauge VABB was performed to identify the underestimation rate of nonpalpable lesions diagnosed as ALH or LCIS at VABB. Thirteen cases of ALH and 36 cases of LCIS were sent to surgery, 29 cases of ALH and 14 cases of LCIS were sent to follow-up. The clinical, mammographic and histologic features were assessed. The correlation between mammographic BI-RADS score and histological B-classification for both ALH and LCIS lesions were performed by Pearson's test. Of 1,765 patients enrolled, lobular lesions (ALH and/or LCIS) occurred in 82 cases, and underestimation arose in 9 (10.9%). Two cases of underestimated ALH were upgraded to invasive lobular carcinoma and one to invasive ductal carcinoma. One case of underestimated LCIS was upgraded to ductal carcinoma in situ, two to invasive ductal carcinoma and three to invasive lobular carcinoma. The histology of the core and surgical specimens were compared. A significant difference was seen in the BI-RADS score (4–5 in 91% of underestimated lesions), and the size of the lesions (≥ 1.5 cm) for underestimated cases versus accurately diagnosed cases (p1.5cm, co-presence of high-risk lesions in the sample, signs of ductal involvement, high histological grading for atypia and follow-up in the other cases. Surgery is recommended in all cases of LCIS:Keywords
This publication has 29 references indexed in Scilit:
- New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesionsClinical Radiology, 2012
- Use of BI-RADS 3–Probably Benign Category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening TrialRadiology, 2011
- Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–A reviewEuropean Journal of Surgical Oncology, 2011
- Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screeningInternational Journal of Cancer, 2010
- Follow-Up of BI-RADS 3 Breast Mammograms, Results of a West France “Departement” Breast Cancer Screening Programme.Cancer Research, 2009
- Lobular neoplasia: Core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic featuresThe Breast, 2008
- Lobular Carcinoma In Situ Diagnosed By Core Needle Biopsy: When Should It Be Excised?Laboratory Investigation, 2003
- The Management of Lobular Neoplasia Identified on Percutaneous Core Breast BiopsyThe Breast Journal, 2003
- Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 CasesLaboratory Investigation, 2002
- Core Needle Biopsy of Challenging Benign Breast ConditionsAmerican Journal of Roentgenology, 2000